Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer

G. F. P. Aleixo,H. Yu,Y. T. Chen,K. A. Nyrop,R. J. Louie,A. M. Deal,S. S. Shachar,H. B. Muss,G. R. Williams
DOI: https://doi.org/10.1007/s10549-020-06061-y
2021-01-10
Breast Cancer Research and Treatment
Abstract:Myosteatosis (intramuscular adiposity) is predictive of chemotherapy toxicity in women undergoing adjuvant chemotherapy for breast cancer (BC). We evaluated a novel, user-friendly and cost-effective technique utilizing a Picture Archiving and Communication Systems (PACS) tool that is readily available in the electronic medical record (EMR), using skeletal muscle density (SMD) to detect myosteatosis and then compared PACS results with those derived from widely used body composition software (SliceOMatic, QC, Canada).
oncology
What problem does this paper attempt to address?